Literature DB >> 10996029

Modulation of collagen-induced arthritis by IL-4 and dexamethasone: the synergistic effect of IL-4 and dexamethasone on the resolution of CIA.

I Kang1, W W Lee, Y Lee.   

Abstract

We investigated effects of IL-4, dexamethasone (DXM), and the combination of IL-4 and DXM, low- or high-dose, on collagen-induced arthritis (CIA) in DBA/1 mice and correlated severity of arthritis with changes in IL-10 and IFN-gamma. Compared with control mice, mice treated with IL-4 had increased IL-10 with the same degree of arthritis, whereas mice treated with high-dose DXM had decreased IL-10 and increased IFN-gamma production with less severe arthritis. Mice treated with low-dose DXM showed the absence of IL-10 and increased IFN-gamma production with a trend toward the resolution of arthritis. Mice treated with IL-4 and low-dose DXM had neither IL-10 nor IFN-gamma production but revealed less severe arthritis, compared with mice treated with low-dose DXM alone. These results suggest that the beneficial effects of high-dose DXM and the combination of IL-4 and DXM on CIA are independent of IL-10 and IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10996029     DOI: 10.1016/s0162-3109(00)00248-4

Source DB:  PubMed          Journal:  Immunopharmacology        ISSN: 0162-3109


  9 in total

1.  Collagen-induced arthritis: severity and immune response attenuation using multivalent N-acetyl glucosamine.

Authors:  J Richter; K Capková; V Hříbalová; L Vannucci; I Danyi; M Malý; A Fišerová
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

2.  Antibody-based delivery of IL4 to the neovasculature cures mice with arthritis.

Authors:  Teresa Hemmerle; Fabia Doll; Dario Neri
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205

3.  Antibody-based targeted delivery of interleukin-4 synergizes with dexamethasone for the reduction of inflammation in arthritis.

Authors:  Anja Sophie Schmid; Teresa Hemmerle; Francesca Pretto; Anja Kipar; Dario Neri
Journal:  Rheumatology (Oxford)       Date:  2018-04-01       Impact factor: 7.580

4.  A highly selective, orally active inhibitor of Janus kinase 2, CEP-33779, ablates disease in two mouse models of rheumatoid arthritis.

Authors:  Kristine L Stump; Lily D Lu; Pawel Dobrzanski; Cynthia Serdikoff; Diane E Gingrich; Ben J Dugan; Thelma S Angeles; Mark S Albom; Mark A Ator; Bruce D Dorsey; Bruce A Ruggeri; Matthew M Seavey
Journal:  Arthritis Res Ther       Date:  2011-04-21       Impact factor: 5.156

5.  Dopamine D2 Receptor Is Involved in Alleviation of Type II Collagen-Induced Arthritis in Mice.

Authors:  Jian-Hua Lu; Yi-Qian Liu; Qiao-Wen Deng; Yu-Ping Peng; Yi-Hua Qiu
Journal:  Biomed Res Int       Date:  2015-11-29       Impact factor: 3.411

6.  Specificity Evaluation and Disease Monitoring in Arthritis Imaging with Complement Receptor of the Ig superfamily targeting Nanobodies.

Authors:  Fang Zheng; Harris Perlman; Patrick Matthys; Yurong Wen; Tony Lahoutte; Serge Muyldermans; Shemin Lu; Patrick De Baetselier; Steve Schoonooghe; Nick Devoogdt; Geert Raes
Journal:  Sci Rep       Date:  2016-10-25       Impact factor: 4.379

7.  Development of a 64Cu-labeled CD4+ T cell targeting PET tracer: evaluation of CD4 specificity and its potential use in collagen-induced arthritis.

Authors:  Anne Skovsbo Clausen; Camilla Christensen; Esben Christensen; Sigrid Cold; Lotte Kellemann Kristensen; Anders Elias Hansen; Andreas Kjaer
Journal:  EJNMMI Res       Date:  2022-09-16       Impact factor: 3.434

8.  Monoacylglycerol Lipase Inhibition Using JZL184 Attenuates Paw Inflammation and Functional Deficits in a Mouse Model of Inflammatory Arthritis.

Authors:  Sara R Nass; Floyd F Steele; Timothy B Ware; Adam H Libby; Ku-Lung Hsu; Steven G Kinsey
Journal:  Cannabis Cannabinoid Res       Date:  2021-05-25

9.  Porphyromonas gingivalis facilitates the development and progression of destructive arthritis through its unique bacterial peptidylarginine deiminase (PAD).

Authors:  Katarzyna J Maresz; Annelie Hellvard; Aneta Sroka; Karina Adamowicz; Ewa Bielecka; Joanna Koziel; Katarzyna Gawron; Danuta Mizgalska; Katarzyna A Marcinska; Malgorzata Benedyk; Krzysztof Pyrc; Anne-Marie Quirke; Roland Jonsson; Saba Alzabin; Patrick J Venables; Ky-Anh Nguyen; Piotr Mydel; Jan Potempa
Journal:  PLoS Pathog       Date:  2013-09-12       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.